(2S,3S)-ethyl 3-((2S)-1-(4-hydroxyphenethylamino)-3-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate

ID: ALA2368877

PubChem CID: 22298595

Max Phase: Preclinical

Molecular Formula: C20H28N2O6

Molecular Weight: 392.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)NCCc1ccc(O)cc1)[C@@H](C)CC

Standard InChI:  InChI=1S/C20H28N2O6/c1-4-12(3)15(22-19(25)16-17(28-16)20(26)27-5-2)18(24)21-11-10-13-6-8-14(23)9-7-13/h6-9,12,15-17,23H,4-5,10-11H2,1-3H3,(H,21,24)(H,22,25)/t12-,15-,16-,17-/m0/s1

Standard InChI Key:  RZHVVXDUYUESJI-STECZYCISA-N

Molfile:  

     RDKit          2D

 28 29  0  0  0  0  0  0  0  0999 V2000
   -0.9681   -5.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9693   -6.8232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2544   -7.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4620   -6.8227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4591   -5.9922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2562   -5.5830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2546   -8.0610    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2587   -4.7580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4545   -4.3434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4521   -3.5184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1653   -3.1038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8810   -3.5141    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1628   -2.2788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8761   -1.8641    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4471   -1.8684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4447   -1.0434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2661   -2.2830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2710   -0.6330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8736   -1.0391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5868   -0.6245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1579   -0.6288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4080   -0.6226    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9933    0.0906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9893    0.9156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7018    1.3316    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2729    1.3247    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6978    2.1566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4103    2.5726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  6
  3  7  1  0
 13 15  1  0
  3  4  2  0
 15 16  1  0
  6  8  1  0
 15 17  1  1
 16 18  1  0
  8  9  1  0
 14 19  1  0
  4  5  1  0
 20 19  1  6
  9 10  1  0
 19 21  2  0
 22 20  1  0
 23 22  1  0
 20 23  1  0
  2  3  1  0
 10 11  1  0
  5  6  2  0
 23 24  1  1
 11 12  2  0
 24 25  1  0
  6  1  1  0
 24 26  2  0
 11 13  1  0
 25 27  1  0
  1  2  2  0
 27 28  1  0
M  END

Associated Targets(Human)

LGMN Tchem Legumain (255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctsl Cathepsin L (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Protease, putative (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.45Molecular Weight (Monoisotopic): 392.1947AlogP: 0.91#Rotatable Bonds: 10
Polar Surface Area: 117.26Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.50CX Basic pKa: CX LogP: 1.76CX LogD: 1.75
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.40Np Likeness Score: 0.01

References

1. Kato D, Boatright KM, Berger AB, Nazif T, Blum G, Ryan C, Chehade KA, Salvesen GS, Bogyo M..  (2005)  Activity-based probes that target diverse cysteine protease families.,  (1): [PMID:16407991] [10.1038/nchembio707]
2. Arastu-Kapur S, Ponder EL, Fonović UP, Yeoh S, Yuan F, Fonović M, Grainger M, Phillips CI, Powers JC, Bogyo M..  (2008)  Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.,  (3): [PMID:18246061] [10.1038/nchembio.70]

Source